Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?

• click to rate

  Posted by Two Blokes Jun 27 - Filed in Stock - 4 views
  
  Up-and-coming telehealth company Hims & Hers Health (HIMS 11.98%) has capitalized on the weight loss drug craze to become one of the market's top performers over the past few years.